Condensed Consolidated Statements of Earnings (unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2026	Sep. 30, 2025	Sep. 30, 2026	Sep. 30, 2025
Income Statement [Abstract]
Net Sales	$ 2,062.9	$ 2,001.4	$ 6,326.6	$ 5,987.7
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Cost of products sold, excluding intangible asset amortization	$ 594.5	$ 559.3	$ 1,806.1	$ 1,701.3
Type of Cost, Good or Service [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember	us-gaap:ProductMember
Intangible asset amortization	$ 166.0	$ 176.5	$ 491.5	$ 488.2
Research and development	105.9	115.9	314.1	339.8
Selling, general and administrative	855.0	811.4	2,604.2	2,384.9
Restructuring and other cost reduction initiatives	14.4	21.4	50.5	74.9
Acquisition, integration, divestiture and related	19.6	(34.4)	53.3	55.0
Operating expenses	1,755.4	1,650.1	5,319.7	5,044.1
Operating Profit	307.6	351.3	1,006.8	943.6
Other (expense) income, net	(2.5)	3.3	(3.7)	10.1
Interest expense, net	(74.9)	(75.4)	(216.6)	(220.9)
Earnings before income taxes	230.1	279.2	786.5	732.8
Provision for income taxes	37.2	48.0	155.7	165.6
Net Earnings	192.9	231.2	630.9	567.2
Less: Net earnings attributable to noncontrolling interest	1.3	0.3	2.8	1.4
Net Earnings of Zimmer Biomet Holdings, Inc.	$ 191.6	$ 230.9	$ 628.1	$ 565.8
Earnings Per Common Share
Basic	$ 1.01	$ 1.17	$ 3.26	$ 2.85
Diluted	$ 1	$ 1.16	$ 3.25	$ 2.84
Weighted Average Common Shares Outstanding
Basic	190.5	198.1	192.6	198.3
Diluted	191.4	198.8	193.4	199.0